An Overview of MYC and Its Interactome

Conacci-Sorrell, M., McFerrin, L., Eisenman, R. N.·2014·Cold Spring Harbor Perspectives in Medicine

Cited by (412)

Items 101–200 of 412

  1. JQ1, a small molecule inhibitor of BRD4, suppresses cell growth and invasion in oral squamous cell carcinoma
    Limei Wang, Xiuyin Wu, Ping Cheong Huang, Zhijun Lv, Yuping Qi, Xiujuan Wei, Pishan Yang, Fenghe Zhang · 2016 · Oncology Reports
  2. MYC-induced metabolic stress and tumorigenesis
    Adam J. Wolpaw, Chi Van Dang · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  3. Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes
    S. P. Singh, Rakesh Bhaskar, Shampa Ghosh, Bhuvaneshwar Yarlagadda, Dr. Krishna Kumar Singh, Prashant Verma, Sonali Sengupta, Mitko I. Mladenov, Nikola Hadzi‐Petrushev, Radoslav Stojchevski et al. · 2025 · Cancers
  4. LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription
    Wan‐Xin Peng, Rongzhang He, Ziqiang Zhang, Liu Yang, Yin‐Yuan Mo · 2019 · Oncogene
  5. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice
    Weiqi Zhang, Jennifer Meyfeldt, Huabo Wang, Sucheta Kulkarni, Jie Li Lu, Jordan A. Mandel, Brady Marburger, Ying Liu, Joanna E. Gorka, Sarangarajan Ranganathan et al. · 2019 · Journal of Biological Chemistry
  6. PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer
    Xin Jin, Rui Fang, Ping Fan, Zeng Lipeng, Bin Zhang, Xiaoming Lu, Tao Liu · 2019 · Journal of Experimental & Clinical Cancer Research
  7. Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature
    Alejandro Vázquez‐Martín, Olga V. Anatskaya, Alessandro Giuliani, Jekaterina A. Erenpreisa, Sui Huang, Kristīne Salmiņa, Inna Inashkina, Anda Huna, Nikolay N. Nikolsky, Alexander E. Vinogradov · 2016 · Oncotarget
  8. Oncogenic MYC amplifies mitotic perturbations
    Samantha Littler, Olivia Sloss, Bethany Geary, Andrew Pierce, Anthony David Whetton, Stephen S. Taylor · 2019 · Open Biology
  9. Deubiquitinating c-Myc: USP36 steps up in the nucleolus
    Xiao‐Xin Sun, Rosalie C. Sears, Mu‐Shui Dai · 2015 · Cell Cycle
  10. Cellular MYCro Economics: Balancing MYC Function with MYC Expression
    David Levens · 2013 · Cold Spring Harbor Perspectives in Medicine
  11. Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia
    Cheng-Long Hu, Bingyi Chen, Zijuan Li, Tianbiao Yang, Chunhui Xu, Ruirui Yang, Pengcheng Yu, Jingyao Zhao, Ting Liu, Na Liu et al. · 2022 · Cell Research
  12. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
    Ka Iong Chan, Siyuan Zhang, Guodong Li, Yida Xu, Liao Cui, Yitao Wang, Huanxing Su, Wen Tan, Zhangfeng Zhong · 2024 · Aging and Disease
  13. MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation
    Sarah Anderson, Kumud Raj Poudel, Minna Roh‐Johnson, Thomas Brabletz, Ming Yu, Nofit Borenstein‐Auerbach, William Grady, Jihong Bai, Cecilia B. Moens, Robert N. Eisenman et al. · 2016 · Proceedings of the National Academy of Sciences
  14. CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer
    Jiayin Sun, Hui Zhang, Dan Tao, Fei Xie, Feng Liu, Chaohui Gu, Miao Wang, Liang Wang, Guosong Jiang, Zhendi Wang et al. · 2019 · Artificial Cells Nanomedicine and Biotechnology
  15. Small interfering RNA–mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma
    Khalil Hajiasgharzadeh, Mohammad Hossein Somi, Dariush Shanehbandi, Ahad Mokhtarzadeh, Behzad Baradaran · 2018 · Journal of Cellular Physiology
  16. Longitudinal transcriptome-wide gene expression analysis of sleep deprivation treatment shows involvement of circadian genes and immune pathways
    Jerome C. Foo, Nina Trautmann, Carsten Sticht, Jens Treutlein, Josef Frank, Fabian Streit, Stephanie H. Witt, Carolina De La Torre, Steffen Conrad von Heydendorff, Lea Sirignano et al. · 2019 · Translational Psychiatry
  17. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation
    Philipp Raffeiner, Jonathan Ross Hart, Daniel García-Caballero, Liron Bar‐Peled, Marc S. Weinberg, Peter K. Vogt · 2020 · Proceedings of the National Academy of Sciences
  18. Strategies to target the cancer driver MYC in tumor cells
    Leonie I. Weber, Markus Hartl · 2023 · Frontiers in Oncology
  19. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer
    Erik S. Knudsen, A. Kathleen McClendon, Jorge Franco, Adam Ertel, Paolo M. Fortina, Agnieszka Katarzyna Witkiewicz · 2015 · Cell Cycle
  20. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway
    Min Dong, Li‐ping Gong, Jianning Chen, Xiaofang Zhang, Yi-wang Zhang, Dayang Hui, Xiaoxiao Zhao, Xiang-yuan Wu, Chun‐Kui Shao · 2020 · Cellular Oncology
  21. The Quest for Targets Executing MYC-Dependent Cell Transformation
    Markus Hartl · 2016 · Frontiers in Oncology
  22. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer
    Eduard Stefan, Klaus Bister · 2017 · Current topics in microbiology and immunology
  23. MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
    Saurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, Ronald J. Bernardi, Zaowen Chen, Eveline Barbieri, Jan Köster, Giovanni Perini, Cristian Coarfa, Jason Matthew Shohet · 2018 · Oncotarget
  24. Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair
    Tatjana Marinković, Dragan Marinković · 2021 · Molecular Neurobiology
  25. MYC the oncogene from hell: Novel opportunities for cancer therapy
    Adriana Papadimitropoulou, Maria Makri, Grigoris Zoidis · 2024 · European Journal of Medicinal Chemistry
  26. Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes
    Elena V. Tchetina, Galina A. Markova · 2018 · Rheumatology International
  27. The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
    Raffaella Pippa, Maria Dolores Odero · 2020 · Cells
  28. Super-enhancers: A new frontier for glioma treatment
    Meng Cheng, Zheng Wei Zhang, Xing Ji, Yadi Xu, Erbao Bian, Bing Zhao · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  29. Targeting MYC at the intersection between cancer metabolism and oncoimmunology
    Simran Venkatraman, Brinda Balasubramanian, Chanitra Thuwajit, Jarek Meller, Rutaiwan Tohtong, Somchai Chutipongtanate · 2024 · Frontiers in Immunology
  30. The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis
    Jason M. Link, Peter J. Hurlin · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  31. Noncoding RNA Ginir functions as an oncogene by associating with centrosomal proteins
    Suchismita Panda, Meenakshi Setia, Navjot Kaur, Varsha Shepal, Vivek Arora, Divya Kumari Singh, Abir Mondal, Abhishek Teli, Madhura Tathode, Rajendra P. Gajula et al. · 2018 · PLoS Biology
  32. Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma
    Hiroyuki Yoda, Takahiro Inoue, Yoshinao Shinozaki, Jason Ching‐Yao Lin, Takayoshi Watanabe, Nobuko Koshikawa, Atsushi Takatori, Hiroki Nagase · 2018 · Cancer Research
  33. Restriction of memory B cell differentiation at the germinal center B cell positive selection stage
    Amparo Toboso-Navasa, Arief Suryono Gunawan, Giulia Morlino, Rinako Nakagawa, Andrea Taddei, Djamil Damry, Yash Patel, Probir Chakravarty, Martin Janz, George Kassiotis et al. · 2020 · The Journal of Experimental Medicine
  34. Targeting MYC: From understanding its biology to drug discovery
    Julie Ross, Caitlin E. Miron, Jessica Plescia, Patricia LaPlante, Kevin M. McBride, Nicolas Moitessier, Tarik Möröy · 2020 · European Journal of Medicinal Chemistry
  35. Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cells
    Yu Gyoung Tak, Yuli Hung, Lijing Yao, Matthew Grimmer, Albert Do, Mital S. Bhakta, Henriette O’Geen, David Jay Segal, Peggy Farnham · 2016 · Nucleic Acids Research
  36. MYC, Cell Competition, and Cell Death in Cancer: The Inseparable Triad
    Simone Di Giacomo, Manuela Sollazzo, Simona Paglia, Daniela Grifoni · 2017 · Genes
  37. Bcl‑2 family: Novel insight into individualized therapy for ovarian cancer (Review)
    Jing Yuan, Hua Lan, Xiao‐Yan Jiang, Da Xing Zeng, Songshu Xiao · 2020 · International Journal of Molecular Medicine
  38. Gene Transactivation and Transrepression in MYC-Driven Cancers
    Marika Scafuro, Lucia Capasso, Vincenzo Carafa, Lucia Altucci, Angela Nebbioso · 2021 · International Journal of Molecular Sciences
  39. The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics
    Zhao Deng, Des Raymond Richardson · 2023 · Pharmacological Reviews
  40. Target of Rapamycin Complex 2 regulates cell growth via Myc in Drosophila
    Ying Kuo, Huanwei Huang, Tao Cai, Tao Wang · 2015 · Scientific Reports
  41. Sin3b Interacts with Myc and Decreases Myc Levels
    Pablo García‐Sanz, Andrea Quintanilla, M. Carmen Lafita‐Navarro, Gema Moreno‐Bueno, Lucia García-Gutiérrez, Vedrana Tabor, Ignacio Varela, Yuzuru Shiio, Lars-Gunnar Larsson, Francisco Portillo et al. · 2014 · Journal of Biological Chemistry
  42. A novel inhibitor L755507 efficiently blocks c-Myc–MAX heterodimerization and induces apoptosis in cancer cells
    Ashutosh Kumar Singh, Ankur Kumar, Prateek Kumar, Namyashree Nayak, Taniya Bhardwaj, Rajanish Giri, Neha Garg · 2021 · Journal of Biological Chemistry
  43. In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
    Philipp Raffeiner, Ruth Röck, Andrea Schraffl, Markus Hartl, Jonathan Ross Hart, Kim D. Janda, Peter K. Vogt, Eduard Stefan, Klaus Bister · 2014 · Oncotarget
  44. MNT and Emerging Concepts of MNT‐MYC Antagonism
    Guang Yang, Peter J. Hurlin · 2017 · Genes
  45. PAF1 complex component Leo1 helps recruit Drosophila Myc to promoters
    Jennifer M. Gerlach, Michael Furrer, Maria Gallant, Dirk Birkel, Apoorva Baluapuri, Elmar Wolf, Peter Gallant · 2017 · Proceedings of the National Academy of Sciences
  46. m1A inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC/PD-L1 signaling
    Shu‐Jin Li, Feng Tian, Yuan‐Tong Liu, Qi‐Chao Yang, An Song, Shuo Wang, Jun Xie, Junjie Zhang, Bi‐Feng Yuan, Zhi‐Jun Sun · 2024 · International Journal of Oral Science
  47. Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide
    Huiyuan Zhang, Qinyi Wang, Junzhong Gu, Le Yin, Shenghui Liang, Lida Wu, Hao Xu, Chao Zhao, Yuchun Gu · 2018 · Oncogene
  48. Identification of MYC as an antinecroptotic protein that stifles RIPK1–RIPK3 complex formation
    Daehyeon Seong, Manhyung Jeong, Jinho Seo, Ji-Yoon Lee, Chi Hyun Hwang, Ho‐Chul Shin, Jeong Yoon Shin, Youngwoo Nam, Jeong Yeon Jo, Haeseung Lee et al. · 2020 · Proceedings of the National Academy of Sciences
  49. Hydra myc2, a unique pre-bilaterian member of the myc gene family, is activated in cell proliferation and gametogenesis
    Markus Hartl, Stella M.K. Glasauer, Taras Valovka, Kathrin Breuker, Bert Hobmayer, Klaus Bister · 2014 · Biology Open
  50. Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis
    Rasanpreet Kaur, Saurabh K. Gupta, Sunanda Kulshrestha, Vishal Khandelwal, Swadha Pandey, Anil Kumar, Gaurav Sharma, Umesh Kumar, Deepak Parashar, Kaushik Das · 2024 · Cells
  51. Detours to Replication: Functions of Specialized DNA Polymerases during Oncogene-induced Replication Stress
    Wei-Chung Tsao, Kristin A. Eckert · 2018 · International Journal of Molecular Sciences
  52. WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1
    Feng Wang, Jiayi Zhang, Xiaoxue Ke, Wen Peng, Gaichao Zhao, Shihan Peng, Jie Xu, Bo Xu, Hongjuan Cui · 2020 · Biochemical and Biophysical Research Communications
  53. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis
    Narumi Suzuki, Yoshikazu Johmura, Teh-Wei Wang, Toshiro Migita, Wenwen Wu, Rei Noguchi, Kiyoshi Yamaguchi, Yoichi Furukawa, Shuhei Nakamura, Ichiro Miyoshi et al. · 2021 · Autophagy
  54. Combinatorial Control of Recruitment of a Variant PRC1.6 Complex in Embryonic Stem Cells
    Yikai Huang, Wukui Zhao, Congcong Wang, Yaru Zhu, Mengjie Liu, Huan Tong, Yin Yan Xia, Qing Yan Jiang, Jinzhong Qin · 2018 · Cell Reports
  55. Investigation of expressions of PDK 1, PLK 1 and c‐Myc in diffuse large B‐cell lymphoma
    Yuhua Feng, Jinguan Lin, Yiping Liu, Youhong Tang, Yangying Zhou, Meizuo Zhong · 2019 · International Journal of Experimental Pathology
  56. MTA1 coregulator regulates LDHA expression and function in breast cancer
    Rohith Kumar Guddeti, Prerna Bali, Prashanthi Karyala, Suresh B. Pakala · 2019 · Biochemical and Biophysical Research Communications
  57. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease
    Almira Kurbegovic, Marie Trudel · 2020 · Cellular Signalling
  58. C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors
    Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi et al. · 2020 · Current Cancer Drug Targets
  59. Intrinsically Disordered Proteins as Regulators of Transient Biological Processes and as Untapped Drug Targets
    Yusuke Hosoya, Junko Ohkanda · 2021 · Molecules
  60. The structure of INI 1/ hSNF 5 RPT 1 and its interactions with the c‐ MYC : MAX heterodimer provide insights into the interplay between MYC and the SWI / SNF chromatin remodeling complex
    Susan Sammak, Mark D. Allen, Najoua Hamdani, Mark Bycroft, Giovanna Zinzalla · 2018 · FEBS Journal
  61. Unraveling MYC’s Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance
    Zinab O. Doha, Rosalie C. Sears · 2023 · Pathophysiology
  62. The brain acid‐soluble protein 1 (BASP1) interferes with the oncogenic capacity of MYC and its binding to calmodulin
    Markus Hartl, Kane Puglisi, Andrea Nist, Philipp Raffeiner, Klaus Bister · 2020 · Molecular Oncology
  63. Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature
    Chao Yang, Jason Siebert, Robert Burns, Yongwei Zheng, Ao Mei, Benedetta B. Bonacci, Demin Wang, Raul A. Urrutia, Matthew John Riese, Sridhar Rao et al. · 2020 · eLife
  64. The many lives of Myc in the pancreatic β-cell
    Carolina Rosselot, Sharon Baumel-Alterzon, Yansui Li, Gabriel Brill, Luca Lambertini, Liora S. Katz, Geming Lu, Adolfo Garcı́a-Ocaña, Donald K. Scott · 2020 · Journal of Biological Chemistry
  65. The role of alternative pre-mRNA splicing in cancer progression
    Sunkyung Choi, Namjoon Cho, Eun-Mi Kim, Kee Kwang Kim · 2023 · Cancer Cell International
  66. Hsp90 as a “Chaperone” of the Epigenome
    Jennifer S. Isaacs · 2015 · Advances in cancer research
  67. L- MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells
    Zhongqi Li, Diana Oganesyan, Rachael Mooney, Xianfang Rong, Matthew J. Christensen, David Shahmanyan, Patrick M. Perrigue, Joseph Benetatos, Lusine Tsaturyan, Soraya Aramburo et al. · 2016 · Stem Cell Reports
  68. Mga safeguards embryonic stem cells from acquiring extraembryonic endoderm fates
    Jinzhong Qin, Congcong Wang, Yaru Zhu, Ting Su, Lixia Dong, Yikai Huang, Kunying Hao · 2021 · Science Advances
  69. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle
    Juan M. Caraballo, Juan Carlos Acosta, M. Alicia Cortés, Marta Albajar, María Teresa Gómez‐Casares, Ana Batlle‐López, M A Cuadrado, Arantza Onaindía, Gabriel Bretones, Javier Llorca et al. · 2014 · Oncotarget
  70. Otx2 is a target of N-myc and acts as a suppressor of sensory development in the mammalian cochlea
    Victor Vendrell, Iris López‐Hernández, María Beatriz Durán Alonso, Ana Feijoo Redondo, Gina Abelló, Héctor Gálvez, Fernando Giráldez, Thomas Lamonerie, Thomas Schimmang · 2015 · Development
  71. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC
    Sander B. Frank, Penny L. Berger, Mats E. Ljungman, Cindy K. Miranti · 2017 · Journal of Cell Science
  72. E3 Ubiquitin Ligase RLIM Negatively Regulates c-Myc Transcriptional Activity and Restrains Cell Proliferation
    Rui Gao, Lan Wang, Hao Cai, Jingjing Zhu, Long Yu · 2016 · PLoS ONE
  73. Inhibition of cIAP1 as a strategy for targeting c-MYC–driven oncogenic activity
    Haoyan Li, Yanjia Fang, Chunyi Niu, Hengyi Cao, Ting Mi, Hong Zhu, Junying Yuan, Jidong Zhu · 2018 · Proceedings of the National Academy of Sciences
  74. Inhibition of Myc transcriptional activity by a mini‐protein based upon Mxd1
    Mark J. Demma, Michael J. Hohn, Angie Sun, Claudio Mapelli, Brian E. Hall, Abbas M. Walji, Jennifer O’Neil · 2020 · FEBS Letters
  75. Evolutionary Conservation of Transcription Factors Affecting Longevity
    Guillermo Martínez-Corrales, Nazif Alic · 2020 · Trends in Genetics
  76. Cross‐talk between Myc and p53 in B‐cell lymphomas
    Yu Li, Tiantian Yu, Ken H. Young · 2019 · Chronic Diseases and Translational Medicine
  77. The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis
    Patrick A. Carroll, Brian W. Freie, Pei Feng Cheng, Sivakanthan Kasinathan, Haiwei Gu, Theresa Hedrich, James A. Dowdle, Vivek Venkataramani, Vijay Ramani, Xiaoying Wu et al. · 2021 · PLoS Biology
  78. Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents
    W-B Tsai, Y Long, J-R Park, Jeffrey T. Chang, Hui Liu, Jaime Rodriguez‐Canales, Niramol Savaraj, Lynn G. Feun, Michael A. Davies, Ignacio Ivan Wistuba et al. · 2015 · Oncogene
  79. Functional interplay between c‐Myc and Max in B lymphocyte differentiation
    Mercedes Pérez‐Olivares, Alfonsina Trento, Sara Rodríguez‐Acebes, Daniel González‐Acosta, David Fernández‐Antorán, Sara Román‐García, Dolores Martínez, Tania López‐Briones, Carlos Torroja, Yolanda R. Carrasco et al. · 2018 · EMBO Reports
  80. Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development
    Kotohiko Kimura, Tiffany L. B. Jackson, Ru Chih C. Huang · 2023 · Current Issues in Molecular Biology
  81. Transcription factor engineering in CHO cells for recombinant protein production
    Matías Gutiérrez-González, Yesenia Latorre, Roberto Zúñiga, Juan Carlos Aguillón, Marı́a Carmen Molina, Claudia Altamirano · 2019 · Critical Reviews in Biotechnology
  82. The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells
    David A. Anderson, Theresa L. Murphy, Robert N. Eisenman, KENNETH M. M. MURPHY · 2020 · Proceedings of the National Academy of Sciences
  83. Post-Translational Regulation of ARF: Perspective in Cancer
    Jinho Seo, Daehyeon Seong, Seung Ri Lee, Doo‐Byoung Oh, Jaewhan Song · 2020 · Biomolecules
  84. MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis
    M. Carmen Lafita‐Navarro, Rosa E. Blanco, Jorge Mata-Garrido, Judit Liaño-Pons, Olga Tapia, Lucia García-Gutiérrez, Eva García-Alegría, Maria Teresa Berciano, Miguel Lafarga, Javier León · 2016 · Oncotarget
  85. Tyrosine phosphorylation of both STAT5A and STAT5B is necessary for maximal IL-2 signaling and T cell proliferation
    Jian-Xin Lin, Meili Ge, Chengyu Liu, Ronald J. Holewinski, Þorkell Andrésson, Zu‐Xi Yu, Tesfay Gebregiorgis, Rosanne J. Spolski, Peng Li, Warren J. Leonard · 2024 · Nature Communications
  86. The deubiquitinase USP38 promotes cell proliferation through stabilizing c-Myc
    Zhijun Xu, Hao Quan Hu, Debao Fang, Jiong Wang, Kailiang Zhao · 2021 · The International Journal of Biochemistry & Cell Biology
  87. MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
    Alina Castell, Qinzi Yan, Karin Fawkner, Wesam Bazzar, Fan Zhang, Malin Wickström, Mohammad Alzrigat, Marcela Franco, Cecilia C. Krona, Donald P. Cameron et al. · 2022 · Cancer Research Communications
  88. N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis
    Wan‐Xin Peng, Fei Liu, Jiahong Jiang, Hang Yuan, Ziqiang Zhang, Liu Yang, Yin‐Yuan Mo · 2022 · Genes & Diseases
  89. Upregulation of ribosome biogenesis via canonical E-boxes is required for Myc-driven proliferation
    Norman Zielke, Anna Vähärautio, Jianping Liu, Teemu Kivioja, Jussi Taipale · 2022 · Developmental Cell
  90. The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex
    Dimitrios Papadopoulos, Stefanie Anh Ha, Daniel Fleischhauer, Leonie Uhl, Timothy J. Russell, Ivan Mikičić, Katharina Schneider, Annika Brem, Omkar Rajendra Valanju, Giacomo Cossa et al. · 2024 · Molecular Cell
  91. Calcium-dependent binding of Myc to calmodulin
    Philipp Raffeiner, Andrea Schraffl, Thomas C. Schwarz, Ruth Röck, Karin Ledolter, Markus Hartl, Robert Konrat, Eduard Stefan, Klaus Bister · 2016 · Oncotarget
  92. Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models
    Ravi Salgia, Isa Mambetsariev, Blake Hewelt, Srisairam Achuthan, Haiqing Li, Valeriy A. Poroyko, Yingyu Wang, Martin Sattler · 2018 · Oncotarget
  93. The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability.
    Yun Jeong Lee, Eun‐Young Lee, Bo Hee Choi, Hyonchol Jang, Jae‐Kyung Myung, Hye Jin You · 2020 · PubMed Central
  94. Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology
    Yingying Duan, Zhaoshuo Liu, Qilin Wang, Junyou Zhang, Jiaxin Liu, Ziyi Zhang, Chunyan Li · 2024 · Genes & Diseases
  95. Her-2/Neu and Myc Gene Silencing in Breast Cancer: Therapeutic Potential and Advancement in Nonviral Nanocarrier Systems
    Jananee Padayachee, Aliscia Nicole Daniels, Adhika Balgobind, Mario Ariatti, Moganavelli Singh · 2020 · Nanomedicine
  96. Role of ARK5 in cancer and other diseases (Review)
    Guoheng Mo, Bohan Zhang, Qunguang Jiang · 2021 · Experimental and Therapeutic Medicine
  97. MYC inhibitors in multiple myeloma
    Sandra Martínez-Martín, Laura Soucek · 2021 · Cancer Drug Resistance
  98. G1/S restriction point coordinates phasic gene expression and cell differentiation
    Brian DeVeale, Leqian Liu, Ryan M. Boileau, Jennifer Swindlehurst-Chan, Bryan Marsh, Jacob W. Freimer, Adam R. Abate, Robert H. Blelloch · 2022 · Nature Communications
  99. MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis
    Juliana Cazarin, Rachel E. DeRollo, Siti Noor Ain Binti Ahmad Shahidan, Jamison B. Burchett, Daniel Mwangi, Saikumari Krishnaiah, Annie Lee Hsieh, Zandra E. Walton, Rebekah C. Brooks, Stephano S. Mello et al. · 2023 · PLoS Genetics
  100. Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level
    Xianjing Hu, Sarwat Fatima, Minting Chen, Tao Huang, Yuen Wa Chen, Rui‐Hong Gong, Hoi Leong Xavier Wong, Rongmin Yu, Liyan Song, Hiu Yee Kwan et al. · 2021 · Cell Death and Disease